Time:
All Today Tomorrow This Week This Month

Bispecific antibodies structural design, production and purification strategies

Join this webinar to gain insights into the diverse applications, design considerations and production strategies of bispecific antibodies (BsAb). You will learn about how bispecific antibodies (BsAb) enable new therapeutic applications

12-08-2023 Dr. Xiaoyu Chen, Protein Senior Scientist, GenScrip

Learn More

Cyclic Peptides in the Spotlight: New Technologies to Synthesize Your Dream Structures

As one of the most effective peptide modification strategies, cyclization imparts distinct biochemical and therapeutic properties to peptides for drug development, such as increased half-life and cell permeability.

12-07-2023 Dr. Mina Wang, Senior Peptide Scientist, R&D Department, GenScript Biotech

Learn More

Circular RNA Synthesis and Lipid Nanoparticle Delivery: A Comprehensive Solution for Enhanced RNA Therapeutics

The approval of messenger RNA (mRNA)-based COVID-19 vaccines marked a scientific turning point, establishing mRNA as a novel drug modality with significant therapeutic potential. However, linear mRNAs have a short half-life and require base modifications

11-07-2023 Dr. Kevin Chen, Director of mRNA & Plasmid

Learn More

Get western blot done in 3 hours: Ways to streamline your WB process

Western blotting is the most commonly used technique in the lab. However, the multi-step workflow is complex and time consuming. This webinar will give a quick review of instrument-based one-stop solutions to accelerate protein analysis through streamlini

11-01-2023 Dr. John Yu, Product Marketing Manager, GenScript

Learn More

Adaptive Immune Response in Narcolepsy Type 1

Join this webinar to learn about the adaptive immune response in narcolepsy type 1 (NT1), including peptide binding affinity to human leukocyte antigen (HLA), the isolation of antigen-HLA restricted CD4+ T cells, and single-cell RNA sequencing of CD4+ T c

10-06-2023 Dr. Guo Luo, Immunologist and Instructor, Stanford University School of Medicine

Learn More

Unleashing the Power of Non-Viral Gene Editing: Transforming Cell Therapy Development

With the fast progress and deeper understanding of CAR-T cell therapy, finding a better solution other than lentivirus transduction is more requested, to overcome the functional limitation on random insertion, uncontrolled copy number of CAR insertion and

09-28-2023 Dr. Lumeng Ye, Director of Novel Therapeutic Material Development, R&D Department, GenScript Biotech

Learn More

< 1 2 3 4 5 6 7 8 9 10 11 > Total Pages 36